SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-012040
Filing Date
2020-05-05
Accepted
2020-05-05 15:40:43
Documents
1
Period of Report
2020-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9222
  Complete submission text file 0000899243-20-012040.txt   11972
Mailing Address 60 WALL STREET NEW YORK NY 10005
Business Address 60 WALL STREET NEW YORK NY 10005 212-319-7600
Dainippon Sumitomo Pharma Co Ltd (Reporting) CIK: 0001446601 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 20848638

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROIVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (646) 802-3660
Sumitovant Biopharma Ltd. (Reporting) CIK: 0001798244 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 20848637

Mailing Address 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260
Business Address 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260 813-5543-5142
Sumitomo Chemical Co., Ltd. (Reporting) CIK: 0001798550 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 20848639